Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Cervical Cancer

  Free Subscription


03.07.2017

1 Am J Obstet Gynecol
1 BMC Cancer
1 BMJ Case Rep
1 Cad Saude Publica
1 Cell Cycle
1 Curr Oncol Rep
1 Glob Health Action
1 Health Serv Res
1 Int J Cancer
1 Int J Womens Health
1 J Clin Ultrasound
4 J Gynecol Oncol
1 J Obstet Gynaecol Res
1 Kaohsiung J Med Sci
1 LGBT Health
1 Onco Targets Ther
1 Oncol Rep
1 Oncol Res
2 Oncotarget
1 Praxis (Bern 1994)
1 Radiat Oncol
1 Rev Bras Ginecol Obstet
1 Rheumatology (Oxford)
1 Strahlenther Onkol
3 Tumour Biol
1 Zhonghua Fu Chan Ke Za Zhi
1 Zhonghua Liu Xing Bing Xue Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Obstet Gynecol

  1. MATSUO K, Machida H, Horowitz MP, Shahzad MMK, et al
    Risk of metachronous ovarian cancer after ovarian conservation in young women with stage I cervical cancer.
    Am J Obstet Gynecol. 2017 Jun 27. pii: S0002-9378(17)30788.
    PubMed     Text format     Abstract available


    BMC Cancer

  2. KARAGEORGOPOULOU S, Kostakis ID, Gazouli M, Markaki S, et al
    Prognostic and predictive factors in patients with metastatic or recurrent cervical cancer treated with platinum-based chemotherapy.
    BMC Cancer. 2017;17:451.
    PubMed     Text format     Abstract available


    BMJ Case Rep

  3. LIMA PC, Teixeira J, Aires GN, Andrade LA, et al
    Endocervical gastric-type adenocarcinoma, an unrelated HPV tumour: difficulties in screening and diagnosis.
    BMJ Case Rep. 2017;2017.
    PubMed     Text format     Abstract available


    Cad Saude Publica

  4. CUROTTO M, Barletta P, Paolino M, Arrossi S, et al
    [Health agents' perspective on the incorporation of self-collected samples in HPV screening programs].
    Cad Saude Publica. 2017;33:e00138515.
    PubMed     Text format     Abstract available


    Cell Cycle

  5. BO H, Weiyang C, Zhang Y
    p53R2 is oncogenic in human cervical cancer.
    Cell Cycle. 2017 Jun 28:1-2. doi: 10.1080/15384101.2017.1337978.
    PubMed     Text format    


    Curr Oncol Rep

  6. ZIGRAS T, Lennox G, Willows K, Covens A, et al
    Early Cervical Cancer: Current Dilemmas of Staging and Surgery.
    Curr Oncol Rep. 2017;19:51.
    PubMed     Text format     Abstract available


    Glob Health Action

  7. MELAN K, Janky E, Macni J, Ulric-Gervaise S, et al
    Epidemiology and survival of cervical cancer in the French West-Indies: data from the Martinique Cancer Registry (2002-2011).
    Glob Health Action. 2017;10:1337341.
    PubMed     Text format     Abstract available


    Health Serv Res

  8. SABIK LM, Tarazi WW, Hochhalter S, Dahman B, et al
    Medicaid Expansions and Cervical Cancer Screening for Low-Income Women.
    Health Serv Res. 2017 Jun 30. doi: 10.1111/1475-6773.12732.
    PubMed     Text format     Abstract available


    Int J Cancer

  9. CARLANDER C, Wagner P, Svedhem V, Elfgren K, et al
    Impact of immunosuppression and region of birth on risk of cervical intraepithelial neoplasia among migrants living with HIV in Sweden.
    Int J Cancer. 2016 May 13. doi: 10.1002/ijc.30188.
    PubMed     Text format     Abstract available


    Int J Womens Health

  10. PIYATHILAKE CJ, Badiga S, Borak SG, Weragoda J, et al
    A higher degree of expression of DNA methyl transferase 1 in cervical cancer is associated with poor survival outcome.
    Int J Womens Health. 2017;9:413-420.
    PubMed     Text format     Abstract available


    J Clin Ultrasound

  11. AKBAS T, Ugurluer G, Acil M, Arpaci T, et al
    Intraoperative sonographic guidance for intracavitary brachytherapy of cervical cancer.
    J Clin Ultrasound. 2017 Jun 27. doi: 10.1002/jcu.22510.
    PubMed     Text format     Abstract available


    J Gynecol Oncol

  12. LORA D, Gomez de la Camara A, Fernandez SP, Enriquez de Salamanca R, et al
    Prognostic models for locally advanced cervical cancer: external validation of the published models.
    J Gynecol Oncol. 2017.
    PubMed     Text format     Abstract available

  13. LIM S, Lee KB
    Use of a cognitive computing system for treatment of cervical cancer.
    J Gynecol Oncol. 2017.
    PubMed     Text format    

  14. DONG L, Feng RM, Zhang L, Xu XQ, et al
    Prospective comparison of hybrid capture 2 and SPF(1)(0)-LiPA for carcinogenic human papillomavirus detection and risk prediction of cervical cancer: a population-based cohort study in China.
    J Gynecol Oncol. 2017.
    PubMed     Text format     Abstract available

  15. SHIM SH, Kim H, Sohn IS, Hwang HS, et al
    Nationwide cervical cancer screening in Korea: data from the National Health Insurance Service Cancer Screening Program and National Cancer Screening Program, 2009-2014.
    J Gynecol Oncol. 2017.
    PubMed     Text format     Abstract available


    J Obstet Gynaecol Res

  16. SABEENA S, Bhat P, Kamath V, Arunkumar G, et al
    Possible non-sexual modes of transmission of human papilloma virus.
    J Obstet Gynaecol Res. 2017;43:429-435.
    PubMed     Text format     Abstract available


    Kaohsiung J Med Sci

  17. XU JZ, Wen F, Wang XR
    The eIF3a Arg803Lys genetic polymorphism is associated with susceptibility to and chemoradiotherapy efficacy in cervical carcinoma.
    Kaohsiung J Med Sci. 2017;33:187-194.
    PubMed     Text format     Abstract available


    LGBT Health

  18. MCDOWELL M, Pardee DJ, Peitzmeier S, Reisner SL, et al
    Cervical Cancer Screening Preferences Among Trans-Masculine Individuals: Patient-Collected Human Papillomavirus Vaginal Swabs Versus Provider-Administered Pap Tests.
    LGBT Health. 2017 Jun 30. doi: 10.1089/lgbt.2016.0187.
    PubMed     Text format     Abstract available


    Onco Targets Ther


  19. Disruption of human papillomavirus 16 E6 gene by clustered regularly interspaced short palindromic repeat/Cas system in human cervical cancer cells [Retraction].
    Onco Targets Ther. 2017;10:2835.
    PubMed     Text format     Abstract available


    Oncol Rep

  20. SUN CY, Chu ZB, Huang J, Chen L, et al
    siRNA-mediated inhibition of endogenous brainderived neurotrophic factor gene modulates the biological behavior of HeLa cells.
    Oncol Rep. 2017;37:2751-2760.
    PubMed     Text format     Abstract available


    Oncol Res

  21. YANG M, Zhai X, Ge T, Yang C, et al
    MiR-181a-5p Promotes Proliferation and Invasion, and Inhibits Apoptosis of Cervical Cancer Cells via Regulating Inositol Polyphosphate-5-Phosphatase A (INPP5A).
    Oncol Res. 2017 Jun 23. doi: 10.3727/096504017X14982569377511.
    PubMed     Text format     Abstract available


    Oncotarget

  22. LI B, Li X, Xiong H, Zhou P, et al
    Inhibition of COX2 enhances the chemosensitivity of dichloroacetate in cervical cancer cells.
    Oncotarget. 2017 Jun 16. doi: 10.18632/oncotarget.18518.
    PubMed     Text format     Abstract available

  23. SU PH, Hsu YW, Huang RL, Weng YC, et al
    Methylomics of nitroxidative stress on precancerous cells reveals DNA methylation alteration at the transition from in situ to invasive cervical cancer.
    Oncotarget. 2017 Jun 6. doi: 10.18632/oncotarget.18370.
    PubMed     Text format     Abstract available


    Praxis (Bern 1994)

  24. BODE-LESNIEWSKA B, Caduff R

    Praxis (Bern 1994). 2017;106:305-310.
    PubMed     Text format    


    Radiat Oncol

  25. FENG Z, Tao C, Zhu J, Chen J, et al
    An integrated strategy of biological and physical constraints in biological optimization for cervical carcinoma.
    Radiat Oncol. 2017;12:64.
    PubMed     Text format     Abstract available


    Rev Bras Ginecol Obstet

  26. DUARTE DV, Vieira RC, Brito EB, Pinheiro MDCN, et al
    Prevalence of Human Papillomavirus Infection and Cervical Cancer Screening among Riverside Women of the Brazilian Amazon.
    Rev Bras Ginecol Obstet. 2017 Jun 28. doi: 10.1055/s-0037-1604027.
    PubMed     Text format     Abstract available


    Rheumatology (Oxford)

  27. WADSTROM H, Arkema EV, Sjowall C, Askling J, et al
    Cervical neoplasia in systemic lupus erythematosus: a nationwide study.
    Rheumatology (Oxford). 2017;56:613-619.
    PubMed     Text format     Abstract available


    Strahlenther Onkol

  28. HASS P, Eggemann H, Costa SD, Ignatov A, et al
    Adjuvant hysterectomy after radiochemotherapy for locally advanced cervical cancer.
    Strahlenther Onkol. 2017 Jun 28. doi: 10.1007/s00066-017-1174.
    PubMed     Text format     Abstract available


    Tumour Biol

  29. JIANG N, Xie F, Guo Q, Li MQ, et al
    Toll-like receptor 4 promotes proliferation and apoptosis resistance in human papillomavirus-related cervical cancer cells through the Toll-like receptor 4/nuclear factor-kappaB pathway.
    Tumour Biol. 2017;39:1010428317710586.
    PubMed     Text format     Abstract available

  30. PANG H, Yue X
    MiR-205 serves as a prognostic factor and suppresses proliferation and invasion by targeting insulin-like growth factor receptor 1 in human cervical cancer.
    Tumour Biol. 2017;39:1010428317701308.
    PubMed     Text format     Abstract available

  31. KIRO NE, Hamblin MR, Abrahamse H
    Photobiomodulation of breast and cervical cancer stem cells using low-intensity laser irradiation.
    Tumour Biol. 2017;39:1010428317706913.
    PubMed     Text format     Abstract available


    Zhonghua Fu Chan Ke Za Zhi

  32. NI J, Yin ZM, Yuan SH, Liu NF, et al
    [A randomized study of intensity-modulated radiation therapy versus three dimensional conformal radiation therapy for pelvic radiation in patients of post-operative treatment with gynecologic malignant tumor].
    Zhonghua Fu Chan Ke Za Zhi. 2017;52:168-174.
    PubMed     Text format     Abstract available


    Zhonghua Liu Xing Bing Xue Za Zhi

  33. FAN SL, Ding L, Ren ZY, Chen X, et al
    [Effect of extracellular signal-regulated kinas 1/2 expression and HPV16 infection and their interaction in progression of cervical cancerization].
    Zhonghua Liu Xing Bing Xue Za Zhi. 2017;38:96-101.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: